PENDULUM CARE
ActiveSummary
PENDULUM CARE has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €764,519 and a net result of €44,643. Equity is growing by ~9.2% per year across the filed fiscal years. Its solvency ranks better than 63% of 38,911 sector peers (NACE 70, fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
19-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 19 days late
07-08
State Gazette act
Capital & shares · RestructuringDemerger · Accounting effect · Asset distribution12 facts ▸
State Gazette act
Capital & shares · Restructuring
Demerger · Accounting effect · Asset distribution12 facts ▸
- General meeting, 17-07-2026
- Demerger, partiele splitsing, definitieve verwezenlijking
- Accounting effect, 01-01-2026
- Asset distribution, eigendomsoverdracht, delen van de activa en passiva van het vermogen
- Capital decrease, €279.446,71
- Reserve release, 10964.58, 467554.34
- Share cancellation, afsplitting van activa- en passivabestanddelen
- Statutes amendment
- Other statement, financieel plan, artikel 12:74 juncto 5:4 WVV
- Name change, PENDULUM CARE
- Power of attorney
- Shareholding, artikel 2:14, 4° WVV
11-05
State Gazette act
Appointment: JDH Consult (director)Permanent representative: Jolan Dehollander3 facts ▸
State Gazette act
Appointment: JDH Consult (director)
Permanent representative: Jolan Dehollander3 facts ▸
- General meeting, 01-04-2026
- Director appointment, JDH Consult (director)
- Permanent representative, Jolan Dehollander (permanent representative)
03-04
State Gazette act
RestructuringAppointment: Boes & Verrue Bedrijfsrevisoren (company auditor) · Incorporation · Statutes amendment23 facts ▸
State Gazette act
Restructuring
Appointment: Boes & Verrue Bedrijfsrevisoren (company auditor) · Incorporation · Statutes amendment23 facts ▸
- Board meeting, 23-03-2026
- Incorporation, 29-12-2008
- Statutes amendment
- Shareholding, datum algemene vergadering, 1000
- Director in office, Steven Dehollander (director)
- Director in office, Ariane Debruyne (director)
- Director in office, Steven Dehollander (director)
- Director in office, Ariane Debruyne (director)
- Demerger, partiele splitsing, EUR
- Share issue, op naam, 1000
- Declaration, geen bijzondere rechten, geen aandeelhouders met bijzondere rechten
- Declaration, geen bijzondere bezoldiging, aandelen uitgegeven evenredig aan rechten in eigen vermogen
- +11 further facts in this act
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
31-12
Financial
Highest result since 2019net €232,824 ▲6,154%
Net result €232,824, the highest in the series.
31-12
Financial
Equity above €500,000Eq €719,876 ▲47.8%
3 profitable years in a row build equity to €719,876.
30-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
14-04
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
Financial
Back to profitnet €12,800
Net result €12,800 after one loss-making year.
26-04
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-09
Financial
Weakest financial yearnet -€21,722
Net result drops to -€21,722, the lowest in the series; recovery starts the following year.
Show earlier events
30-04
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-04
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
14-05
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 14 days late
2018
29-05
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 29 days late
2017
29-05
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 29 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
3 of 4 acts read
About the unread acts
Of the 4 Belgian State Gazette acts we know for this company, 3 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.